
Sign up to save your podcasts
Or
Ketamine has gone from a recreational psychedelic to an approved treatment, and it has caught on in Silicon Valley in a big way. Are the long-term effects of using ketamine—recreationally or therapeutically—sufficiently known? Are we witnessing them right now?
Guest: Shayla Love, staff writer for the Atlantic.
Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices
4.4
231231 ratings
Ketamine has gone from a recreational psychedelic to an approved treatment, and it has caught on in Silicon Valley in a big way. Are the long-term effects of using ketamine—recreationally or therapeutically—sufficiently known? Are we witnessing them right now?
Guest: Shayla Love, staff writer for the Atlantic.
Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices
9,171 Listeners
8,484 Listeners
3,908 Listeners
1,875 Listeners
998 Listeners
2,858 Listeners
1,027 Listeners
1,020 Listeners
3,488 Listeners
1,377 Listeners
7,841 Listeners
6,666 Listeners
5,645 Listeners
53 Listeners
2,277 Listeners
2,042 Listeners
23,923 Listeners
10,135 Listeners
6,924 Listeners
2,391 Listeners
1,285 Listeners
5,410 Listeners
16,102 Listeners
1,190 Listeners
416 Listeners
15,374 Listeners
59 Listeners
46 Listeners
96 Listeners
4 Listeners
82 Listeners
0 Listeners